Left ventricular hypertrophy (LVH) is associated with an impairment in coronary vasodilator capacity and sometimes also with reduced myocardial function. The aim of the study was to evaluate the relationship between myocardial vascularity reserve (MVR) assessed by myocardial contrast echocardiography (MCE) and indexes of LV chamber and myocardial function; the former measured as endocardial fractional shortening (FS), the latter as midwall fractional shortening corrected for end-systolic wall stress (MFS/ESS) and cyclic variation (CV) of the integrated backscatter signal (IBS). Methods: 12 never treated asymptomatic hypertensive patients with LVH (age 52_+7 years, LV mass index 182_+26 g/sqm) were studied by M-mode echocardiography, IBS and MCE. Using as cut-off for relative wall thickness (RWT) 0.45, LVH was classified as eccentric (EcH) in five and concentric (CoH) in seven patients. MCE was performed in Harmonic Mode (HP, Sonos 5500, 1.8/3.6 MHz, contrast agent Levovist, Schering AG) at baseline and at the end of high-dose dipyridamole infusion (0.84 mg/kg/8 min). Mean grey-level intensity within interventricular septum (IVS) was measured at steady state at baseline and after dipyridamole using previously developed algorithm. After background subtraction (blood grey level intensity) MVR was calculated. CV-IBS was measured in the corresponding area of IVS in parasternal long-axis view at baseline. Results: Hypertensive patients with EcH and Coil were comparable for age, BP, FS and CV-IBS. Compared to EcH, Coil had higher LV mass index (172_+20 vs 206_+23 g/sqm, p<O.01) and lower MVR (1.82-+0.31 vs 1.44_+0.17, p<0.05), and MFS/ESS (110.4_+10 vs 76.7_+17%, p<0.01). In the overall population, MVR was directly related to basal FS (r=0.69, p<0.01), MFS/ESS (r=0.67, p<0.01), p<0.01) and inversely to p<0.01) . Conclusion: Our results with MCE technique suggests a tight interrelationship between LV myocardial and chamber function and perfusion reserve in hypertensive patients with LVH. In addition, concentric pattern of LVH is associated with a lower MVR than the eccentric one.
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Non-invasive assessment of coronary flow velocities and reserve by transthoracic Doppler echocardiography in patients with hypertrophic cardiomyopathy S. Severino, L. De Simone, P.. Caso, A. D'Andrea, AR. Martiniello, M. Scherillo, N. Mininni Cardiology Dept., Monaldi Hosp., Naples, Italy Aim of the study: to evaluate coronary flow velocities (CF) and reserve (CFR) in patients with Hypertrophic Cardiomyopathy (HC) by Transthoracic Doppler Echocardiography (TTE) (Acuson Sequoia). Methods: 13 patients with HC (9 M; 19--71 years) referred for angina and 14 age-matched control subjects, all without significant coronary artery stenosis at angiographic study. They underwent standard Doppler Echocardiography and measurement of CF, at rest and after low-dose dypiridamole infusion, in order to assess CFR in the distal portion of left anterior descending coronary artery. Diastolic and systolic peak velocities (DPV, SPV; m/s) and integrals (DVI, SVI; m/s) were measured. CFR was obtained by the ratio of Dip to baseline DPV. Results: among systolic parameters, both rest and Dip SPV as well as Dip SVI were significantly reduced in HC compared with controls (Rest: SPV=0.15-+0.08 vs 0.21 _+0.07, p<0.05; SV1=0.03_+0.001 vs 0.042_+0.016, p=NS; Dip: SPV=0.18_+0.02 vs 0.46_+0.02, p<0.001; SV1=0.05_+0.001 vs 0.093_+0.003 p< 0.01, respectively). A significant reduction of Dip DPV and DVI was also found in HC compared with controls (0.55_+0.2 vs 0.82_+0.2, p<0.05, and 0.16_+0.07 vs 0.25_+0.06, p<0.05, respectively). On the other hand, rest DPV and DVl showed higher, even not statistically significant, values in HC. CFR appeared to be reduced in HC (1.49_+0.4 vs 2.3_+0.3 in control group; p< 0.001) as a result of combined abnormal baseline and hyperemic CF response. Furthermore, a weak negative correlation was found between septal wall thickness and SPV ( r: -0.33; p<0.01). Conclusions : patients with HC and symptomatic for angina showed abnormalities of systolic and diastolic CF and impairment of CFR despite angiographically normal coronary arteries. As I-IE represent a non-invasive and easy repeatable tool, this technique may allow the evaluation of the effects of different therapeutic approaches in these patients.
Aim of this study is analysis of Coronary Microcirculation (CM) in Athlete's heart in basal conditions and after vasodilatory stimulus (dipyridamole), with quantitative myocardial contrast echocardiography (MCE). Ten healthy subjects (C) and 11 Athletes (bicyclists) (A), all males,(age:26.9-+&7 yr.), without CAD, hypertension, diabetes or obesity. Sonos 5500 (Agilent Technologies) with $4 harmonic transducer was used; Levovist as ultrasonic contrast agent (400mg/ml) was e.v. injected, using an infusion pump. Digitized images of MCE were collected in four chamber views with Power Harmonic Doppler (Anglo) modality, with an end-systolic trigger. After 5 minutes of the stop of contrast, coronary hyperemia was induced with e.v. injection of 0.56 mg/kg of dipyridamole; two minutes after dipyridamole infusion, another Levovist injection was administered, according to previous protocol. Using dedicated PC software, Anglo images, in a colored scale, was analysed placing a ROI on septum. MCE analysis resulted in a time-intensity curve (polinomial fit). The following parameters were analysed : peak intensity (PI) , PI half-time (HT); area under curve of appearance (AUCwi) and disappearance of microbubbles at 2/3 of PI (AUCwo); ratio between PI and AUCwo after dipyridamole and PI and AUCwo at rest, were obtained. The indexed left ventricular mass (LVMi) is significantly higher in A (135g/m2_+25 vs. 105+ 11 in C; p<0.005). PI significantly increases after dipyridamole both in C (p<.001) and in A (p<0.02); the absolute value of PI is significantly higher in A both in basal (p<.002) and after dipyridamole (p<.05). AUCwi is significantly higher in athletes both at rest (p<.001) and after dipyridamole (p<.0001); AUCwi significantly decreases in athletes (p<.02), while in C is substantially unchanged. AUCwo is significantly higher in athletes both at rest (p<.003) and after dipyridamole (p<.02); AUCwo significantly increases both in A (p<0.002) and in athletes (p<.03). No difference are detectable between the two groups regarding the ratio of PI and of AUCwo; considered as indirect expression of coronary reserve. Athletes evidentiate an higher number of microbubbles both at rest and after vasodilatory stimulus, also with the normalization of AUCwi and AUCwo by LVMi. These findings demonstrate, in athletes, a large myocardial capillary bed distribution, which is typical of this physiological type of left ventricular hypertrophy. Both groups show a similar coronary reactivity in response to a vasodilator stimulus. The myocardial fixation of I-metaiodobenzylguanidine(MIBG) is recently being used to study the myocardial adrenergic nerve activity and have been found to be reduced in heart failure. This study was undertaken to correlate MIBG cardiac uptake with echocardiographic wall motion score index (WMSI) in patients(pts) with idiopathic dilated cardiomyopathy (ID). Methods: We studied 10 pts (51.+/-12.4 years), on sinus rhythm, with angiographically proven ID, ejection fraction (EF) < 40%, (group A), and 10 healthy age-matched individuals (group B). None of the pts or control subjects had history of of diabetes mellitus. Both groups underwent planar and SPECT myocardial imaging 4 hours after intravenous injection of 5mCi 1-123-MIBG. The heart to mediastinum (H/M) ratio was calculated to quantify cardiac MIBG accumulation, while SPECT study was performed to investigate the regional distribution of adrenergic innervation. A four point score system was used to determinate the 1-123-MIBG accumulation (0-3 normalabsence of 1-123-MIBG uptake). Both groups underwent an echocardiographic study and WMSI was assessed using a four point scoring system (1-4, normal-diskynesia). Interpretation of myocardial adrenergic innervation and regional wall motion was performed, using a 5-segment model (IVS, apex, anterior, lateral, posterior ) . Results: H/M ratio was less in group A than in group B (1.4+/-0.18 vs 2.0+/-0.34, p=0.001). There was significant correlation between H/M ration and LV EF (r=0.5, p<0.001) and cardiac index(r=0.55, p<0.001) in group A. In SPECT study all pts had regional alterations in adrenergic innervation (10/10pts). The echocardiographic study showed regional wall motion abnormalities in 40/50 segments. There was a segmental correlation between the wall motion abnormalities and the alteration in adrenergic innervation. The WMSI was significanty correlated with the severity of the alteration in the adrenergic innervation (r=0.6,p<0.01). Conclusions: MIBG reduction in pts with idiopathic dilated cardiomyopathy is related to the severity of LV wall motion abnormalities. Microvascular alteration in the regions of reduced adrenergic innervatien may be responsible for the wall motion abnormalities in those patients. The aim of this study was to evaluate the effect of 3-month bisoprolol therapy on coronary flow reserve (CRF) assessed using transoesophageal Doppler echocardiography (TEE-DOPPLER) in patients (pts) with dilated cardiomyopathy (DC). Material and method: CFR was assessed in 14 male pts (mean age 54+11 years) with DC before treatment, 2 weeks and 3 months after start of bisoprolol therapy. All pts had angiographically normal coronary arteries. At rest and after intravenous infusion of dipyridamole (0.84 mg/kg/10 min), peak systolic and diastolic coronary flow velocities were measured in the proximal part of the left anterior descending coronary artery using TEE-DOPPLER. CFR was calculated as a ratio of maximal systolic and diastolic coronary flow velocity after dipyridamole infusion to maximal systolic and diastolic coronary flow velocity at baseline. Results: Systolic and diastolic coronary flow reserve (sCFR, dCFR) were signifi-cantly lower in studied pts before and 2 week after bisoprorol treatment compared with the same pts after 3 months bisoprolol therapy. The results of sCFR and dCFR for studied group before and after bisoprolol treatment are presented in the table below. BEFORE THERAPY AFTER THERAPY 2 weeks 3 months sCFR 1.40_+0.43 1.36_+0.27 1.67_+0.52* dCFR 1.52_+0.34 1.49_+0.33 1.69_+0.25" *CFR before therapy vs CFR after 3-month therapy -p<0.035. Conclusions: The study confirms the decrease of coronary flow reserve in patients with dilated cardiomyopathy, and shows improvement of this parameter after 3-month bisoprolol therapy. In patients with systemic hypertension LV geometric pattern has been shown to be related to LV systolic function at midwall level (MFS) and to cardiovascular risk. The aim of the study was to evaluate coronary vasodilator capacity in hypertensive subjects with different LV geometry and MFS, and to compare them with data obtained in normctensive controls (NC). Methods: Fifty-four subjects were studied, including 11 NC and 43 hypertensive patients -8 with normal LV mass and geometry (NG), 16 with concentric remodeling (CoR) and 19 with concentric LV hypertrophy (Coil). CAD was excluded (Holter, exercise ECG, echodipyridamole in all, angiography in 32 subjects). Under continuous monitoring of blood pressure (BP) and heart rate, mean flow velocity in left anterior descending artery was monitored by TEE-Doppler at baseline and during maximal flow response to Adenosine (700 IJg/Kg/5 min), and minimum coronary resistance (MCR; mmHg*s*cm-1) was calculated. In addition resistance reserve (RR) was calculated as ratio between basal coronary resistance and MCR. LV mass index (g/sgm), relative wall thickness (RWT), endocardial fractional shortening (EFS; %), MFS corrected for meridional end-systolic wall stress (MFS/ESS; %) were assessed by M-mode echo. Results: hypertensive and normotensive subjects were comparable for age, and the different groups of hypertensive patients were comparable for BP. As compared to NC, MCR was decreased in all hypertensive groups (0.84__.0.15 vs 1.25±0.36 in NG, 1.28+0.26 in CoR, 1.21 ±0.30 in Coil, mmHg*s*cm-1, p<0.01 for all), while RR was slightly decreased in NG (3.76+0.7 vs 3.18+0.3, p=0.06) and significantly decreased in CoR and Coil (2.76_+0.5 and 2.71±0.6, p<0.01). In CoR and CoH (88±15% and 89±13%,p<0.05), but not in NG (104_+11%), MFS/ESS was significanfty decreased as compared to NC (101 ±7%). Conclusions: In systemic hypertension MCR is already decreased even in absence of LV hypertrophy. Concentric remodeling and concentric LV hypertrophy had similarly decreased vasodilating capacity. These findings indicate that, despite normal LV mass, concentric remodeling seems to represent an entity very close to that of concentric hypertrophy.
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